
## **Trustees’ Annual Report for the period** 

**From 1 January 2022   To 31 December 2022** 

**Charity name: Arrhythmogenic Cardiomyopathy Trust** 

## **Charity registration number: 1176790** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|TO PROMOTE AND PROTECT GOOD HEALTH FOR<br>THE PUBLIC BENEFIT, RELATING TO INHERITED<br>HEART CONDITIONS AND IN PARTICULAR<br>ARRYTHMOGENIC CARDIOMYOPATHY BY<br>FUNDING RESEARCH PROJECTS, SUCH PROJECTS<br>CAN BE DIAGNOSTIC, CURATIVE, THERAPEUTIC<br>OR PALLIATIVE IN NATURE AND TO ENSURE THE<br>PUBLICATION OF THE USEFUL RESULTS OF SUCH<br>RESEARCH.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or services<br>identified in the accounts.|Para 1.17 and<br>1.19|Further fundraising. Second tranche of grant<br>made to UCL for project “A Clinical and<br>Molecular Platform for Disease Stratification in<br>Arrhythmogenic Cardiomyopathy.” Project will<br>complete in October 2023.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|This guidance has been noted by the trustees of<br>the charity.|



## **Achievements and Performance** 

SORP reference 



||Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|During the year, the charity has successfully<br>raised a further £4,293 to support its objectives<br>of funding medical research projects focussed on<br>Arrhythmogenic Cardiomyopathy, a heart<br>muscle disease that affects young people. This<br>means that the charity has raised almost<br>£155,000 to achieve its objectives.<br>Following the receipt of a satisfactory progress<br>report for the research project undertaken by<br>UCL ‘Disease Stratification in Arrhythmogenic<br>Cardiomyopathy,’ we were pleased to release<br>the second tranche payment of £57,651 in the<br>year. The project is due to conclude in October<br>2023, after which its findings will be presented<br>to the trustees.|
|---|---|---|---|





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of theperiod|Para 1.21|The charity had cash reserves of £25,007 at year<br>end. The charity holds only cash deposits, with<br>no debt.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|Reserves will be held on an ongoing basis until a<br>research project is successfully funded.|
|Amount of reserves held|Para 1.22|£25,007|
|Reasons for holding zero<br>reserves|Para 1.22|n/a|
|Details of fund materially in<br>deficit|Para 1.24|n/a|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|No concerns|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|CIO governing document|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees appointed by resolution of existing<br>trustees|



## **Reference and Administrative details** 


**----- Start of picture text -----**<br>
Charity name Arrhythmogenic Cardiomyopathy Trust<br>Other name the charity uses ACT<br>Registered charity number  1176790<br>Charity’s principal address  97 Rosebank, Holyport Road, London, SW6 6LJ<br>**----- End of picture text -----**<br>




**Names of the charity trustees who manage the charity** 


**----- Start of picture text -----**<br>
Dates acted if not for whole  Name of person (or body) entitled<br>Trustee name  Office (if any)<br>year to appoint trustee (if any)<br>1 James Minch  Trustee<br>2 Kate Minch  Trustee<br>3 Rachel Bailey Trustee<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20<br>**----- End of picture text -----**<br>


– Corporate trustees names of the directors at the date the report was approved 

## **Director name** 


Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets n/a held in this capacity Name and objects of the n/a charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for n/a safe custody and segregation of such assets from the charity’s own assets 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signatures(s)** Rachel Bailey **Full name(s)** James Minch **Position (eg Secretary,** Trustee Trustee **Chair, etc) Date** 31.10.23 




**Arrhythmogenic Cariomyopathy Trust 1176790 Receipts and payments accounts CC16a For the period** 01/01/2022 31/12/2022 **To from** 

## **Section A Receipts and payments** 


**----- Start of picture text -----**<br>
Unrestricted  Restricted  Endowment<br>Total funds Last year<br>funds funds funds<br>to the nearest<br>to the nearest £ to the nearest £ to the nearest £ to the nearest £<br>£<br>A1 Receipts<br>Income                       4,923                              -                                -                          4,923                    48,591<br>                            -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>Sub total  (Gross income for<br>                      4,923                              -                                -                          4,923                    48,591<br>AR)<br>A2 Asset and investment sales,<br>(see table).<br>                              -                                -                                -                              -<br>                              -                                -                                -                              -                                -<br>Sub total                                -                                -                                -                              -                                -<br>Total receipts                   4,923                            -                            -                        4,923                 48,591<br>A3 Payments<br>Expenses                          137                              -                                -                             137                         562<br>Grant's made                     57,651                              -                                -                        57,651                    57,651<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>                              -                              -                                -                                -                              -<br>Sub total [                    57,788 ]                             -                                -                        57,788                    58,213<br>A4 Asset and investment<br>purchases, (see table)<br>                              -                                -                                -                              -<br>                              -                                -                                -                              -<br>Sub total [                              - ]                               -                                -                              -                                -<br>Total payments                 57,788                            -                            -                      57,788                 58,213<br>Net of receipts/(payments) -               52,864                          -                            -   -               52,864  -                9,622<br>A5 Transfers between funds                           -                          -                           -                                -                          -<br>A6 Cash funds last year end                  77,871                          -                           -                    77,871                        -<br>Cash funds this year end                 25,007                          -                            -                   25,007  -                9,622<br>**----- End of picture text -----**<br>


CCXX R1 accounts (SS) 

31/10/2023 

1 



|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|
|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>**Details**<br>Signature|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**25,007**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**25,007**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>James Minch|**Endowment**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**When due**<br>**(optional)**<br>Date of<br>approval<br>31.12.23|



CCXX R2 accounts (SS) 

31/10/2023 

2 

